Pursuits
Bayer, Apple, Spanx, Grumpy Cat, Coke: Intellectual Property
This article is for subscribers only.
A unit of Bayer AG, Germany’s largest drugmaker, sued India’s Glenmark Generics Ltd. seeking to stop sales of a generic form of its Finacea gel used to treat rosacea.
Glenmark, based in Mumbai, is seeking U.S. Food and Drug Administration approval for a generic version of the drug before Bayer’s patent 6,534,070 expires in 2018, according to a complaint filed March 14 in federal court in Wilmington, Delaware.